Patient examples from LIBTAYO trials

Patient example 1

This is an example from the 30% (58 out of 193 patients) of patients who saw tumors shrink (partial response) in 1 clinical trial with LIBTAYO.

Pictured below is an ear tumor from a 57-year-old male patient.

He had CSCC that could not be cured by surgery or radiation.

This patient had a response that lasted approximately 20 months. At the time of data collection, 26 months (3 months after completing treatment with LIBTAYO as per the study plan), the patient's disease had worsened (image not available).

Patient example 2

This is an example from the 30% (58 out of 193 patients) of patients who saw tumors shrink (partial response) in 1 clinical trial with LIBTAYO.

Pictured below is a neck tumor from an 85-year-old male patient.

He had CSCC that had spread, or metastasized, to other parts of the body.

This patient had a response that lasted 37+ months. At the time of data collection, 39 months (16 months after completing treatment with LIBTAYO as per the study plan), the patient's response was still ongoing (image not available).

Patient example 3

This is an example from the 17% (33 out of 193 patients) of patients who saw tumors completely disappear (complete response) in 1 clinical trial with LIBTAYO.

Pictured below are chest lesions from a 66-year-old male patient.

He had CSCC that had spread, or metastasized, to other parts of his body.

This patient had a response that lasted 31+ months. At the time of data collection, 37 months (14 months after completing treatment with LIBTAYO as per the study plan), the patient's response was still ongoing (image not available).